Sort by
Keyphrases
Cytochrome P450 2C9 (CYP2C9)
100%
Phenytoin
100%
Epilepsy Treatment
100%
Pharmacogenetics
60%
Adverse Reactions
60%
Metabolism
40%
Polymorphism
40%
High Risk
40%
Individual Dose
20%
Fast Metabolizers
20%
Metabolic Profile
20%
Poor Metabolizer
20%
Therapeutic Range
20%
Serum Concentration
20%
Ibero-America
20%
Epilepsy
20%
Risk to Humans
20%
Informed Consent
20%
Enzymatic Profile
20%
Gene Family
20%
Health Systems
20%
Health Sciences
20%
Saturable
20%
DNA Extraction
20%
Venous Blood
20%
Blood Samples
20%
Fast-slow
20%
English Language
20%
Annex 1
20%
School of Medicine
20%
Drug Response
20%
Pharmacogenomics
20%
Allele Frequency
20%
Genetic Unit
20%
Antiepileptic Drugs
20%
Health Risk
20%
Monotherapy
20%
Genetic Characteristics
20%
Genetic Polymorphism
20%
CYP2C9 Gene
20%
PCR Amplification
20%
School Health
20%
Cytochrome Genes
20%
Risk of Death
20%
Spanish Language
20%
Allelic Variants
20%
DNA Analysis
20%
People with Epilepsy
20%
Genotype Frequency
20%
Blood Levels
20%
Anticonvulsant
20%
Hardy-Weinberg Equilibrium
20%
Biochemistry, Genetics and Molecular Biology
Allele
100%
CYP2C9
100%
Pharmacogenetics
100%
Metabolic Pathway
66%
Blood Level
66%
Pharmacogenomics
33%
Enzyme
33%
Multigene Family
33%
DNA Extraction
33%
Genetic Trait
33%
Spanish (Language)
33%
English (Language)
33%
Cytochrome
33%
Genetic Polymorphism
33%
Sample Size
33%
Genetics
33%
Pharmacology, Toxicology and Pharmaceutical Science
Phenytoin
100%
CYP2C9
100%
Epilepsy
100%
Pharmacogenetics
60%
Adverse Event
60%
Anticonvulsive Agent
40%
Monotherapy
20%
Pharmacogenomics
20%
Cytochrome
20%
Enzyme
20%